Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
Epidemiol Infect
    July 2026
  1. NAQVI OH, Wendelboe AM, Beasley WH, Tyungu DL, et al
    Epidemiological characteristics of paediatric COVID-19 and influenza co-infections in the United States, 2020-2024.
    Epidemiol Infect. 2026;154:e105.
    >> Share

    June 2026
  2. AMEMIYA Y, Nishiura H
    Using forensic autopsy data to estimate the age-specific infection fatality risk of COVID-19.
    Epidemiol Infect. 2026;154:e96.
    >> Share

  3. DAVOODI Z, Laurie C, Tingley K, Skidmore B, et al
    Risk-of-bias assessment of vaccine effectiveness studies: a scoping review of systematic reviews.
    Epidemiol Infect. 2026;154:e95.
    >> Share

  4. MCGEOCH L, Stoker K, Rome M, Carey C, et al
    What is the burden of respiratory syncytial virus outbreaks in care homes? An enhanced surveillance study in England, winter 2024/25.
    Epidemiol Infect. 2026;154:e99.
    >> Share

    May 2026
  5. NEMCOVA B, Goldstein IH, Sebastian J, Minin VM, et al
    Unjustified Poisson assumptions lead to overconfident estimates of the effective reproductive number.
    Epidemiol Infect. 2026;154:e79.
    >> Share

  6. SANE J
    Rebuilding trust in public health: Beyond polarization.
    Epidemiol Infect. 2026;154:e71.
    >> Share

  7. ROSCA EC, Oke J, Jefferson T, Brassey J, et al
    Serial cycle threshold to assess the infectious potential of SARS-CoV-2: A systematic review.
    Epidemiol Infect. 2026;154:e89.
    >> Share

  8. KITAMURA N, Kondo N, Ith S, Okuyama M, et al
    Post-pandemic immunity debt for paediatric infectious diseases in Japan between 2014 and 2024.
    Epidemiol Infect. 2026;154:e67.
    >> Share

  9. HASSELL K, Andrews N, Dabrera G, Kall M, et al
    Acute COVID-19 mortality in England in the omicron era: a national-level matched cohort study.
    Epidemiol Infect. 2026;154:e70.
    >> Share

    April 2026
  10. TOZDUMAN B, Gulle BT
    Influenza Vaccination Coverage and Determinants of Vaccination Among Older Adults in Turkey.
    Epidemiol Infect. 2026 Apr 30:1-17. doi: 10.1017/S0950268826101563.
    >> Share

  11. MORTON LC, Forshey BM, Klinkhammer KE, Romaner A, et al
    Local genomic epidemiology investigations of SARS-CoV-2 during the early pandemic response: A global systematic review.
    Epidemiol Infect. 2026;154:e56.
    >> Share

  12. MILLER AC, Boonstra DE, Cavanaugh JE, Boikos C, et al
    Disease burden associated with influenza activity at the population level.
    Epidemiol Infect. 2026 Apr 6:1-28. doi: 10.1017/S0950268826101320.
    >> Share

    March 2026
  13. GONZALES BE, Ochoa TJ, van der Sande MAB
    Inequalities in complete pneumococcal vaccination among Peruvian children before and after the COVID-19 pandemic: An evaluation using demographic and health surveys from 2018 to 2023.
    Epidemiol Infect. 2026;154:e49.
    >> Share

  14. ABUNIJELA S, Greiner T, Haas W, Kerber R, et al
    Frequency, dynamics, and duration of faecal shedding in SARS-CoV-2-infected individuals, a scoping review.
    Epidemiol Infect. 2026;154:e44.
    >> Share

  15. KIMURA M, Asai Y, Tsuzuki S, Shimizu Y, et al
    Effectiveness of voluntary PCR testing against COVID-19 spread in remote Japanese islands.
    Epidemiol Infect. 2026;154:e48.
    >> Share

  16. JACKSON C, Wijlaars L, Abdullahi F, Liu M, et al
    Paediatric infection hospital admissions in England before, during, and after the COVID-19 pandemic.
    Epidemiol Infect. 2026;154:e33.
    >> Share

    February 2026
  17. TADA A, Otake S, Kusano T, Hoshino T, et al
    Clinical features and trends of severe paediatric group A streptococcal infections in Japan in the post-COVID-19 pandemic era.
    Epidemiol Infect. 2026;154:e35.
    >> Share

  18. UNNIKRISHANAN R, Zhao Y, Burgess CP, Markey PG, et al
    Measuring the excess mortality during the COVID-19 pandemic in the Northern Territory, Australia.
    Epidemiol Infect. 2026;154:e26.
    >> Share

  19. FUNG IC, Liang H, Pierce KJ, Kraay ANM, et al
    Excess mortality in Mainland China after the end of the Zero COVID policy: A systematic review.
    Epidemiol Infect. 2026;154:e29.
    >> Share

    January 2026
  20. CHIEN LC, Chen LA, Gelaw E, Collins CM, et al
    Tracking COVID-19 vaccination barriers over time: a census-tract-level barrier index approach.
    Epidemiol Infect. 2026;154:e20.
    >> Share

  21. MARQUEZ J, Garcia-Garcia D, Vigo MI, Bordehore C, et al
    Retrospective estimate of COVID-19 infections in nine Colombian cities in 2020.
    Epidemiol Infect. 2026;154:e22.
    >> Share

  22. WOLMUTH-GORDON HS, Elgohari S, Dabrera G, Green RE, et al
    Estimating influenza A subtype ratios among critical care admissions in England.
    Epidemiol Infect. 2026 Jan 12:1-8. doi: 10.1017/S0950268825100812.
    >> Share

  23. WANG B, Zhang T, Yi L, Wu Y, et al
    Incidence of community-acquired pneumonia among adults between 2016 and 2023: an observational cohort study.
    Epidemiol Infect. 2026;154:e15.
    >> Share

  24. MURAKAMI M, Yamagata M, Miura A
    The impact of COVID-19 infection experience on risk perception and preventive behaviour: a cohort study.
    Epidemiol Infect. 2026;154:e4.
    >> Share

  25. JIMENEZ-RICO MA, Novelo-Perez DF, Puch-Magana CI, Manrique-Puch RA, et al
    Respiratory virus dynamics in a tropical region: Insights from Yucatan, Mexico (2018-2024).
    Epidemiol Infect. 2026;154:e7.
    >> Share

  26. KOKAVECZ L, Sohajda Z, David P, Stagel A, et al
    Incidence of parvovirus B19 among Hungarian blood donor population during COVID-19 restrictions and the subsequent B19 epidemic of 2024.
    Epidemiol Infect. 2026;154:e11.
    >> Share

  27. DHAWAN S, Pan-Ngum W, MacIntyre CR, Blacksell SD, et al
    Epidemiological indicators of accidental laboratory-origin outbreaks.
    Epidemiol Infect. 2026;154:e16.
    >> Share

    December 2025
  28. JARRATT R, Clough H, Wilkinson E, Vivancos R, et al
    The Eat-Out-to-Help-Out incentive: A trigger for gastrointestinal infections in England, 2020?
    Epidemiol Infect. 2025;154:e3.
    >> Share

  29. BEJKO D, Vergison A, Stranges S, Mossong J, et al
    Protection from second booster vaccines and natural immunity against SARS-CoV-2 infections, 2022-2023.
    Epidemiol Infect. 2025;154:e10.
    >> Share

  30. CAREY C, O'Moore E, Huyton R, Willner S, et al
    COVID-19 outbreaks in care homes: How does size influence transmission dynamics? A cross-sectional study with implications for outbreak management in small care homes.
    Epidemiol Infect. 2025;154:e8.
    >> Share

  31. CAMPOS MENA S, Perez-Gimeno G, Lorusso N, Alvarez Rio V, et al
    Monitoring effectiveness of nirsevimab immunization against RSV hospitalization using surveillance data: a test-negative case-control study, Spain, October 2024-March 2025.
    Epidemiol Infect. 2025;154:e5.
    >> Share

  32. STADHOUDERS L, Hoogteijling EM, Duijts L, Lebon A, et al
    Trends in asthma exacerbations in children before, during, and after the COVID-19 pandemic.
    Epidemiol Infect. 2025;153:e138.
    >> Share

    November 2025
  33. ASPLIN P, Fyles M, Kennedy J, Ward T, et al
    Evaluating Google Trends as a proxy for symptom incidence: insights from the winter COVID-19 infection study in England 2023/24.
    Epidemiol Infect. 2025;153:e136.
    >> Share

  34. CHUA H, Tsang TKL, Lee SL, Chan ELY, et al
    Waning in influenza vaccine effectiveness against influenza A(H1N1)pdm09-associated hospitalization in children in 2012/13.
    Epidemiol Infect. 2025 Nov 24:1-25. doi: 10.1017/S0950268825100770.
    >> Share

    October 2025
  35. MUNCH PK, Hansen CH, Moller FT, Norgaard SK, et al
    COVIDmeter - a questionnaire-based symptom monitoring system for the surveillance of COVID-19 in Denmark, 2020-2023.
    Epidemiol Infect. 2025;153:e134.
    >> Share

  36. GODOY P, Pardos J, Garcia Cenoz M, Parron I, et al
    Mask wearing by COVID-19 index cases reduces SARS-CoV-2 transmission to household contacts.
    Epidemiol Infect. 2025;153:e125.
    >> Share

    September 2025
  37. VAN DER ROEST B, Fischer EAJ, Klinkenberg D, Bootsma MCJ, et al
    Phylodynamic inference suggests introductions as main driver of Mpox Clade II outbreak in 2022 in Slovenia.
    Epidemiol Infect. 2025;153:e115.
    >> Share

  38. WOLDEGIORGIS M, Bloomfield L, Korda R, Cadby G, et al
    Factors associated with persistence or recovery from long COVID 6 months post-SARS-CoV-2 infection.
    Epidemiol Infect. 2025;153:e116.
    >> Share

    August 2025
  39. PARRADO R, Cuba-Grandy CX, Fuentes-Luppichini E, Torrico Villarroel NG, et al
    Multiplex RT-qPCR strategy for SARS-CoV-2 variants detection in developing countries without ngs: The Bolivian experience.
    Epidemiol Infect. 2025;153:e94.
    >> Share

  40. BUBAR K, Middleton C, Larremore D, Gostic K, et al
    A fundamental limit to the effectiveness of traveller screening with molecular tests.
    Epidemiol Infect. 2025;153:e95.
    >> Share

  41. CHOI H, Hwang M, Coppin JD, Chatterjee P, et al
    Penetration of SARS-CoV-2 Alpha, Delta, and Omicron variants in the United States.
    Epidemiol Infect. 2025;153:e92.
    >> Share

    July 2025
  42. WU S, Feng Y, Cheng H, Huang H, et al
    Personalized risk score prediction and testing policy adaptations of a COVID-19 population-based contact tracing network.
    Epidemiol Infect. 2025;153:e90.
    >> Share

  43. DO DA, Duy-Nguyen VM, Nguyen TH, Le DT, et al
    Antibiotic resistance among ICU patients during the COVID-19 pandemic and its associated factors: a retrospective study using electronic medical records in two Vietnamese hospitals.
    Epidemiol Infect. 2025;153:e93.
    >> Share

  44. KELLY GE, Petti S, Noah N
    Excess respiratory, circulatory, neoplasm, and other mortality rates during the Covid-19 pandemic in the EU and their implications.
    Epidemiol Infect. 2025;153:e86.
    >> Share

    June 2025
  45. SMAGGE B, Labuschagne L, Pijpers J, van Roon A, et al
    Factors associated with lower COVID-19 vaccine uptake among populations with a migration background in the Netherlands.
    Epidemiol Infect. 2025;153:e87.
    >> Share

  46. COLEMAN BL, Robertson NM, Harrison RA, Valiquette L, et al
    Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020-2023.
    Epidemiol Infect. 2025;153:e72.
    >> Share

  47. ABEYKOON AMH, Wilson M, Subbarao K, Geard N, et al
    Severe acute respiratory syndrome coronavirus-2 shedding in exhaled material: a systematic review.
    Epidemiol Infect. 2025;153:e75.
    >> Share

  48. BARBER CA, Chien LC, Labus B, Crank K, et al
    Application of joinpoint regression to SARS-CoV-2 wastewater-based epidemiology in Las Vegas, Nevada, USA.
    Epidemiol Infect. 2025;153:e68.
    >> Share

    March 2025
  49. ABUCAR EAM, Kern M, Kurth T, Meierkord A, et al
    Health-related quality of life up to 2 years after SARS-CoV-2 infection: a descriptive cohort study.
    Epidemiol Infect. 2025;153:e60.
    >> Share

  50. STERIAN M, Naganathan T, Corrin T, Waddell L, et al
    Evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition: an updated living systematic review.
    Epidemiol Infect. 2025;153:e62.
    >> Share

  51. CHEN C, Chen D, Du Y, Jiang D, et al
    Global patterns and trends in deaths of influenza-associated lower respiratory infections from 1990 to 2019.
    Epidemiol Infect. 2025;153:e49.
    >> Share

  52. SUOMENRINNE-NORDVIK A, Leino T, Shubin M, Auranen K, et al
    Quantifying the direct and indirect components of COVID-19 vaccine effectiveness during the Delta variant era.
    Epidemiol Infect. 2025;153:e59.
    >> Share

  53. MIN KH, Kim JH, Gil JY, Park JH, et al
    Factors associated with carditis adverse events following SARS-COV-2-19 vaccination.
    Epidemiol Infect. 2025;153:e51.
    >> Share

  54. MONGE S, Humphreys J, Nicolay N, Braeye T, et al
    Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23.
    Epidemiol Infect. 2025;153:e54.
    >> Share

  55. WITTEVEEN-FREIDL G, Lauenborg Moller K, Voldstedlund M, Gubbels S, et al
    Data for action - description of the automated COVID-19 surveillance system in Denmark and lessons learnt, January 2020 to June 2024.
    Epidemiol Infect. 2025;153:e58.
    >> Share

  56. WASIK BR, Damodaran L, Maltepes MA, Voorhees IEH, et al
    THE EVOLUTION AND EPIDEMIOLOGY OF H3N2 CANINE INFLUENZA VIRUS AFTER 20 YEARS IN DOGS.
    Epidemiol Infect. 2025 Mar 5:1-38. doi: 10.1017/S0950268825000251.
    >> Share

    February 2025

  57. Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?
    Epidemiol Infect. 2025;153:e44.
    >> Share

  58. LIN W, Kung KH, Chan CL, Chuang SK, et al
    Characteristics and risk factors associated with COVID-19 reinfection in Hong Kong: a retrospective cohort study.
    Epidemiol Infect. 2025;153:e30.
    >> Share

  59. HOEVE CE, Neppelenbroek N, Vos ERA, Huiberts AJ, et al
    Using SARS-CoV-2 nucleoprotein antibodies to detect (re)infection.
    Epidemiol Infect. 2025;153:e38.
    >> Share

  60. SIMMS I, Charlett A, Colon-Gonzalez FJ, Blomquist PB, et al
    Adapting the Flexible Farrington Algorithm for daily situational awareness and alert system to support public health decision-making during the SARS-CoV-2 epidemic in England.
    Epidemiol Infect. 2025;153:e28.
    >> Share

  61. PASCULLI P, Antonacci M, Zingaropoli MA, Dominelli F, et al
    SARS-CoV-2 vaccination influence in the development of long-COVID clinical phenotypes.
    Epidemiol Infect. 2025;153:e40.
    >> Share

    January 2025
  62. HAYES J, Lee SS, Carnevale J, Shamir D, et al
    Performance and functional assessment of the Kimera P-IV point-of-care plasmonic qPCR prototype for ultra rapid pathogen detection of chlamydia trachomatis.
    Epidemiol Infect. 2025;153:e27.
    >> Share

  63. CAMPMAN SL, Boyd A, Schinkel J, Coyer L, et al
    SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022.
    Epidemiol Infect. 2025;153:e23.
    >> Share

  64. BEDNARSKA NG, Smith S, Bardsley M, Loveridge P, et al
    Trends in general practitioner consultations for hand foot and mouth disease in England between 2017 and 2022.
    Epidemiol Infect. 2025;153:e22.
    >> Share

  65. CHANDA MM, Shivachandra SB, Mishra A, Punnoose P, et al
    Unique duck rearing practice in irrigated rice paddy fields driving recurrent H5N1 Avian Influenza outbreaks in two districts of Kerala, India.
    Epidemiol Infect. 2025 Jan 7:1-36. doi: 10.1017/S0950268824001882.
    >> Share

  66. BROWN J, Mook P, Vanhaverbeke M, Gimma A, et al
    Case-only analysis of routine surveillance data: detection of increased vaccine breakthrough infections with SARS-CoV-2 variants in Europe.
    Epidemiol Infect. 2025;153:e16.
    >> Share

    December 2024
  67. NOSTAEVA A, Shimansky V, Apalko S, Kuznetsov I, et al
    Case-control association study between polygenic risk score and COVID-19 severity in a Russian population using low-pass genome sequencing.
    Epidemiol Infect. 2024;153:e13.
    >> Share

  68. TYRRELL GJ, Croxen M, McCullough E, Li V, et al
    Group A streptococcal infections in Alberta, Canada 2018-2023.
    Epidemiol Infect. 2024;153:e35.
    >> Share

  69. ARASHIRO T, Solante R, Sayo AR, Garcia RM, et al
    Factors associated with COVID-19 in-hospital death and COVID-19 vaccine effectiveness against COVID-19 hospitalization in the Philippines during pre-omicron and omicron period: A case-control study (MOTIVATE-P study).
    Epidemiol Infect. 2024;153:e18.
    >> Share

  70. HUIBERTS AJ, Oosting IJ, de Melker HE, van de Wijgert JHHM, et al
    The effect of SARS-CoV-2 infection and COVID-19 vaccination during pregnancy on neonatal outcomes.
    Epidemiol Infect. 2024;153:e5.
    >> Share

  71. ZHENG C, Yu FY, Chan PS, Sun F, et al
    Receiving three doses of inactivated or mRNA COVID-19 vaccines was associated with lower odds of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China: a cross-sectional survey study.
    Epidemiol Infect. 2024;152:e166.
    >> Share

  72. WANG S, Yan J, Song M, Xue Z, et al
    Development of a nomogram for high antibody titre of COVID-19 convalescent plasma.
    Epidemiol Infect. 2024;152:e167.
    >> Share

  73. SANOGO IN, Fusade-Boyer M, Molia S, Koita OA, et al
    Identification of risk areas for avian influenza outbreaks in domestic poultry in Mali using the GIS-MCDA approach.
    Epidemiol Infect. 2024;152:e152.
    >> Share

    November 2024
  74. WANG W, Li Q, Wang J
    A self-driven ESN-DSS approach for effective COVID-19 time series prediction and modelling.
    Epidemiol Infect. 2024;152:e146.
    >> Share

  75. MARKELZ A, Zirnhelt Z, Morris K, Seys SA, et al
    Association between age of paediatric index cases and household SARS-CoV-2 transmission.
    Epidemiol Infect. 2024;152:e145.
    >> Share

  76. SUTER J, Devos I, Matthes KL, Staub K, et al
    The health and demographic impacts of the "Russian flu" pandemic in Switzerland in 1889/1890 and in the years thereafter.
    Epidemiol Infect. 2024;152:e174.
    >> Share

  77. ZHU W, Tang X, Chen Y, Chen M, et al
    Prediction of SARS-CoV-2 infection cases based on the meta-SEIRS model.
    Epidemiol Infect. 2024;152:e144.
    >> Share

  78. FERRONI E, Mateo-Urdiales A, Bietta C, Cesaroni G, et al
    Sex differences in response to COVID-19 mRNA vaccines in Italian population.
    Epidemiol Infect. 2024;152:e139.
    >> Share

  79. GANDINI S, Conly J, Spencer EA, Evans D, et al
    Oro-faecal transmission of SARS-CoV-2: A systematic review of studies employing viral culture from gastrointestinal and other potential oro-faecal sources and evidence for transmission to humans.
    Epidemiol Infect. 2024;152:e138.
    >> Share

  80. MAO S, Gu D, Wang D, Li P, et al
    Prevalence and prognosis of tinnitus in post-COVID-19 patients: a cross-sectional survey.
    Epidemiol Infect. 2024;152:e137.
    >> Share

    October 2024
  81. YUN C, Lee Y, Heo SJ, Kim N, et al
    The impact of COVID-19 status and vaccine type following the first dose on acute heart disease: A nationwide retrospective cohort study in South Korea.
    Epidemiol Infect. 2024;152:e134.
    >> Share

  82. BEDIR DEMIRDAG T, Ozcicek M, Polat M, Kavas FC, et al
    Effects of COVID-19 pandemic on epidemiological features of viral respiratory tract infections in children: a single-centre study.
    Epidemiol Infect. 2024;152:e128.
    >> Share

  83. PIJNACKER R, Mughini-Gras L, Verhoef L, van den Beld M, et al
    Impact of non-pharmaceutical interventions during the COVID-19 pandemic on pathogens transmitted via food in the Netherlands.
    Epidemiol Infect. 2024;152:e130.
    >> Share

  84. ZHAO J, Huang X, Li X, Li B, et al
    The spatial-temporal variations and influencing factors of COVID-19 case fatality rate: a worldwide study in 30 countries from February 2021 to May 2022.
    Epidemiol Infect. 2024;152:e124.
    >> Share

  85. MCKEE CD, Yu EX, Garcia A, Jackson J, et al
    Superspreading of SARS-CoV-2: a systematic review and meta-analysis of event attack rates and individual transmission patterns.
    Epidemiol Infect. 2024;152:e121.
    >> Share

  86. WANG H, Varol T, Gultzow T, Zimmermann HML, et al
    Spatio-temporal distributions of COVID-19 vaccine doses uptake in the Netherlands: a Bayesian ecological modelling analysis.
    Epidemiol Infect. 2024;152:e119.
    >> Share

  87. SHAW STEWART PD
    Will COVID-19 become mild, like a cold?
    Epidemiol Infect. 2024;152:e120.
    >> Share

  88. PENDREY CGA, Khvorov A, Nghiem S, Rahaman MR, et al
    Hospitalizations and emergency attendance averted by influenza vaccination in Victoria, Australia, 2017 - 2019.
    Epidemiol Infect. 2024;152:e111.
    >> Share

  89. CHARLES H, Sinka K, Simms I, Baker KS, et al
    Trends in shigellosis notifications in England, January 2016 to March 2023.
    Epidemiol Infect. 2024;152:e115.
    >> Share

  90. MOORE HL, Turner C, Rawlinson C, Chen C, et al
    Risk factors for COVID-19 transmission in England: a multilevel modelling study using routine contact tracing data.
    Epidemiol Infect. 2024;152:e112.
    >> Share

    September 2024
  91. ANDREYCHYN M, Melnyk L, Zavidniiuk N, Nychyk N, et al
    Interleukins in the pathogenesis of influenza and other acute respiratory viral infections.
    Epidemiol Infect. 2024;152:e109.
    >> Share

  92. MELTZER HC, Goodwin JL, Fowler LA, Britt TW, et al
    Severe acute respiratory syndrome coronavirus 2-reactive salivary antibody detection in South Carolina emergency healthcare workers, September 2019-March 2020.
    Epidemiol Infect. 2024;152:e102.
    >> Share

  93. CHARLAND K, Pierce L, Saucier A, Hamelin ME, et al
    Omicron incidence and seroprevalence among children in Montreal, Canada, in early 2023: final results from the longitudinal EnCORE serology study.
    Epidemiol Infect. 2024;152:e103.
    >> Share

    August 2024
  94. RIOU J, Studer E, Fesser A, Schuster TM, et al
    Surveillance of SARS-CoV-2 prevalence from repeated pooled testing: application to Swiss routine data.
    Epidemiol Infect. 2024;152:e100.
    >> Share

    June 2024
  95. ALSHAMRANI MM, El-Saed A, Aldayhani O, Alhassan A, et al
    Risk of central line-associated bloodstream infections during COVID-19 pandemic in intensive care patients in a tertiary care centre in Saudi Arabia.
    Epidemiol Infect. 2024;152:e95.
    >> Share

    May 2024
  96. LOVE NK, Jenkins C, McCarthy N, Baker KS, et al
    International travel as a risk factor for gastrointestinal infections in residents of North East England.
    Epidemiol Infect. 2024;152:e97.
    >> Share

  97. LASANDER M, Elo K, Joronen K, Dub T, et al
    Barriers to vaccine acceptance in the adult population of mainland Finland, 2021 - ERRATUM.
    Epidemiol Infect. 2024;152:e79.
    >> Share

  98. YI B, Patrasova E, Simunkova L, Rost F, et al
    Investigating the cause of a 2021 winter wave of COVID-19 in a border region in eastern Germany: a mixed-methods study, August to November 2021.
    Epidemiol Infect. 2024;152:e87.
    >> Share

  99. BERIKOPOULOU MM, Dessypris N, Kalogera E, Petridou E, et al
    Epidemiology of respiratory syncytial virus in hospitalized children before, during, and after the COVID-19 lockdown restriction measures in Greece.
    Epidemiol Infect. 2024;152:e94.
    >> Share

  100. BEALE S, Yavlinsky A, Fong WLE, Nguyen VG, et al
    Long-term outcomes of SARS-CoV-2 variants and other respiratory infections: evidence from the Virus Watch prospective cohort in England.
    Epidemiol Infect. 2024;152:e77.
    >> Share

    April 2024
  101. PARK JO, Cho HK, Jeon CH, Kim SH, et al
    Characteristics and biomarkers associated with mortality in COVID-19 patients presenting to the emergency department.
    Epidemiol Infect. 2024;152:e76.
    >> Share

  102. CHAMBERS T, Anglemyer A, Chen A, Atkinson J, et al
    Population and contact tracer uptake of New Zealand's QR-code-based digital contact tracing app for COVID-19.
    Epidemiol Infect. 2024;152:e66.
    >> Share

  103. TSANG TK, Du RQR, Fang VJ, Lau EHY, et al
    Decreased risk of non-influenza respiratory infection after influenza B virus infection in children.
    Epidemiol Infect. 2024 Apr 8:1-21. doi: 10.1017/S0950268824000542.
    >> Share

  104. GUERRERO-SOLER M, Gras-Valenti P, Gomez-Sotero IL, Platas-Abenza G, et al
    Impact of COVID-19 on the degree of compliance with hand hygiene: a repeated cross-sectional study.
    Epidemiol Infect. 2024;152:e69.
    >> Share

    March 2024
  105. NESTERUK I
    Should we ignore SARS-CoV-2 disease?
    Epidemiol Infect. 2024;152:e57.
    >> Share

  106. PENG L, Huang X, Wang C, Xin H, et al
    Comparative epidemiology of outbreaks caused by SARS-CoV-2 Delta and Omicron variants in China.
    Epidemiol Infect. 2024;152:e43.
    >> Share

  107. MBOUSSOU F, Nkamedjie P, Oyaole D, Farham B, et al
    Rapid assessment of data systems for COVID-19 vaccination in the WHO African Region.
    Epidemiol Infect. 2024;152:e50.
    >> Share

  108. LOZANO D, Dohoo C, Elfstrom D, Carswell K, et al
    COVID-19 outbreak at a residential apartment building in Northern Ontario, Canada.
    Epidemiol Infect. 2024;152:e53.
    >> Share

    February 2024
  109. YAP WK, Attwell K
    Medical exemptions to mandatory vaccinations: The state of play in Australia and a pressure point to watch.
    Epidemiol Infect. 2024;152:e40.
    >> Share

  110. HOEG TB, Haslam A, Prasad V
    The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds.
    Epidemiol Infect. 2024;152:e51.
    >> Share

  111. WAITE LL, Nahhas A, Irvahn J, Garden G, et al
    COVID-19 passenger screening to reduce travel risk and translocation of disease.
    Epidemiol Infect. 2024;152:e36.
    >> Share

  112. GARAY E, Whelan SPJ, DuBois RM, O'Rourke SM, et al
    Immune response to SARS-CoV-2 variants after immunization with different vaccines in Mexico.
    Epidemiol Infect. 2024;152:e30.
    >> Share

    January 2024
  113. YAMAYOSHI S, Nagai E, Mitamura K, Hagihara M, et al
    Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan.
    Epidemiol Infect. 2024;152:e24.
    >> Share

  114. BIRD O, Galiza EP, Baxter DN, Boffito M, et al
    The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
    Epidemiol Infect. 2024;152:e37.
    >> Share

  115. ROSNER BM, Falkenhorst G, Kumpf I, Enssle M, et al
    Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study).
    Epidemiol Infect. 2024;152:e16.
    >> Share

  116. SARKER P, Haq MA, Akhtar E, Roy AK, et al
    Serosurveillance among urban slum and non-slum populations immunized with COVID-19 vaccines in Bangladesh.
    Epidemiol Infect. 2024;152:e14.
    >> Share

  117. LIEPINS T, Davie G, Miller R, Whitehead J, et al
    Rural-urban variation in COVID-19 vaccination uptake in Aotearoa New Zealand: Examining the national roll-out.
    Epidemiol Infect. 2024;152:e7.
    >> Share

    December 2023
  118. SCHWARTZ RA, Suskind RM
    Post-COVID-19 neuropsychiatric manifestations: a suggested therapeutic approach to 'long COVID' with azithromycin.
    Epidemiol Infect. 2023;152:e34.
    >> Share

  119. PARRON I, Carol M, Bes N, Izquierdo C, et al
    The impact of COVID-19 pandemic on the incidence of acute gastroenteritis outbreaks in Catalonia (Spain).
    Epidemiol Infect. 2023;152:e10.
    >> Share

    November 2023
  120. ALEEM MA, Macintyre CR, Rahman B, Islam AKMM, et al
    Association of recent respiratory illness and influenza with acute myocardial infarction among the Bangladeshi population - a case-control study.
    Epidemiol Infect. 2023 Nov 30:1-38. doi: 10.1017/S0950268823001863.
    >> Share

  121. CHAVES-BLANCO L, de Salazar A, Fuentes A, Vinuela L, et al
    Evaluation of a combined detection of SARS-CoV-2 and its variants using real-time allele-specific PCR strategy: an advantage for clinical practice.
    Epidemiol Infect. 2023;151:e201.
    >> Share

  122. GULLE BT, Oren MM, Dal T
    COVID-19 vaccine hesitancy in Turkey: A systematic review and meta-analysis.
    Epidemiol Infect. 2023;151:e199.
    >> Share

  123. ELGERSMA IH, Fretheim A, Elstrom P, Aavitsland P, et al
    Association between face mask use and risk of SARS-CoV-2 infection: Cross-sectional study.
    Epidemiol Infect. 2023;151:e194.
    >> Share

  124. JIANG H, Gu Z, Liu H, Huang J, et al
    Evaluation of phase-adjusted interventions for COVID-19 using an improved SEIR model.
    Epidemiol Infect. 2023;152:e9.
    >> Share

  125. MERINO P, Kupferwasser D, Flores EA, Phan Tran D, et al
    Skin and soft tissue infection incidence before and during the COVID-19 pandemic.
    Epidemiol Infect. 2023;151:e190.
    >> Share

    October 2023
  126. SEGHEZZO G, Nash SG, Aziz NA, Hope R, et al
    Risk of severe outcomes among Omicron sub-lineages BA.4.6, BA.2.75, and BQ.1 compared to BA.5 in England.
    Epidemiol Infect. 2023;151:e189.
    >> Share

  127. DAVID JA, Kolipakkam B, Morales MK, Vissichelli NC, et al
    Cell-free plasma next-generation sequencing assists in the evaluation of secondary pneumonia in patients with COVID-19: a case series.
    Epidemiol Infect. 2023;151:e185.
    >> Share

  128. RODRIGUEZ-DEL-RIO FJ, Barroso P, Fernandez-de-Mera IG, de la Fuente J, et al
    COVID-19 epidemiology and rural healthcare: a survey in a Spanish village.
    Epidemiol Infect. 2023;151:e188.
    >> Share

  129. FLANNAGAN J, Chudasama DY, Hope R, Collin SM, et al
    Attribution of nosocomial seeding to long-term care facility COVID-19 outbreaks.
    Epidemiol Infect. 2023;151:e191.
    >> Share

  130. KIM JY, Lee WJ, Suh JW, Kim SB, et al
    Clinical impact of COVID-19 in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia.
    Epidemiol Infect. 2023;151:e180.
    >> Share

  131. WONG R, Lovier MA
    Racial and ethnic disparities in COVID-19 diagnosis and adherence to mitigation behaviours in a national United States older adult sample.
    Epidemiol Infect. 2023;151:e175.
    >> Share

  132. CANELAS-FERNANDEZ J, Mazagatos C, Delgado-Sanz C, Larrauri A, et al
    Influenza hospitalizations in Spain between the last influenza and COVID-19 pandemics. 2009-2019.
    Epidemiol Infect. 2023 Oct 4:1-32. doi: 10.1017/S0950268823001620.
    >> Share

  133. ZHENG L, Qiu L, Wu L, Wang J, et al
    Association of SARS-CoV-2 viral load with abnormal laboratory characteristics and clinical outcomes in hospitalised COVID-19 patients.
    Epidemiol Infect. 2023;151:e173.
    >> Share

    September 2023
  134. GOPAL RAO G, Jinjika S, James D, Mukombe N, et al
    Nosocomial outbreak in a respiratory ward caused by the SARS-CoV-2 Omicron BA 5.2.1 subvariant associated with non-severe illness in vaccinated patients.
    Epidemiol Infect. 2023;151:e171.
    >> Share

  135. TWOHIG KA, Harman K, Zaidi A, Aliabadi S, et al
    Representativeness of whole-genome sequencing approaches in England: the importance for understanding inequalities associated with SARS-CoV-2 infection.
    Epidemiol Infect. 2023;151:e169.
    >> Share

  136. MITANGALA PN, Irenge LM, Musubao ET, Kahindo JBM, et al
    Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of the Congo.
    Epidemiol Infect. 2023;151:e167.
    >> Share

  137. ZHAO T, Yang Z, Wu Y, Yang J, et al
    Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis.
    Epidemiol Infect. 2023;151:e176.
    >> Share

  138. NDZIESSI G, Niama RF, Aloumba AG, Peya JM, et al
    Seroprevalence of SARS-CoV-2 antibodies in Republic of Congo, February 2022.
    Epidemiol Infect. 2023;151:e162.
    >> Share

  139. AKBARIAN S, Sheikhi M, Khedri P, Baharifar N, et al
    The correlation between humoral immune responses and severity of clinical symptoms in COVID-19 patients.
    Epidemiol Infect. 2023;151:e158.
    >> Share

  140. MELLOR J, Overton CE, Fyles M, Chawner L, et al
    Understanding the leading indicators of hospital admissions from COVID-19 across successive waves in the UK.
    Epidemiol Infect. 2023;151:e172.
    >> Share

    August 2023
  141. GUHA SK, Sadhukhan S, Niyogi S
    COVID-19 cluster identification and support vector machine classifier model construction using global healthcare and socio-economic features.
    Epidemiol Infect. 2023;151:e159.
    >> Share

  142. GOLDSTEIN E
    Mortality associated with Omicron and influenza infections in France before and during the COVID-19 pandemic.
    Epidemiol Infect. 2023 Aug 25:1-22. doi: 10.1017/S0950268823001358.
    >> Share

  143. SZEKELY J, Rakchang W, Rattanaphan P, Kositpantawong N, et al
    Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak.
    Epidemiol Infect. 2023;151:e146.
    >> Share

  144. LOVE NK, Douglas A, Gharbia S, Hughes H, et al
    Understanding the impact of the COVID-19 pandemic response on GI infection surveillance trends in England, January 2020-April 2022.
    Epidemiol Infect. 2023;151:e147.
    >> Share

  145. JENNINGS S, Corrin T, Waddell L
    A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition.
    Epidemiol Infect. 2023;151:e145.
    >> Share

  146. SATALA J, Wozniak A, Fabis M, Gorzelak-Pabis P, et al
    Severe COVID-19 classified by simple covid risk index is associated with higher levels of advanced oxidation protein products and 8-hydroxy 2 deoxyguanosine.
    Epidemiol Infect. 2023;151:e140.
    >> Share

  147. VERONESE G, Mahamid F, Bdier D
    Concerns, perceived risk, and hesitancy on COVID-19 vaccine: a qualitative exploration among university students living in the West Bank.
    Epidemiol Infect. 2023;151:e139.
    >> Share

    July 2023
  148. WALEKHWA AW, Nakazibwe B, Nantongo M, Wafula ST, et al
    COVID-19 second wave and clinical characteristics of cases in Uganda: A retrospective cross-sectional survey of confirmed SARS-CoV-2 cases, March-June 2021.
    Epidemiol Infect. 2023;151:e142.
    >> Share

  149. HALEVI A, Shkalim Zemer V, Embar T, Jacobson E, et al
    Attitudes toward COVID-19 vaccination of healthcare workers in Israel and vaccination rates during vaccine rollout.
    Epidemiol Infect. 2023;151:e132.
    >> Share

  150. DE CARVALHO FS, Slack SD, Barbosa-Junior F, de Campos MR, et al
    Genomic epidemiology of SARS-CoV-2 in large university hospital cohort: the UnCoVER-Brazil project.
    Epidemiol Infect. 2023;151:e126.
    >> Share

  151. FUNK T, Espenhain L, Moller FT, Ethelberg S, et al
    Factors associated with the formation of SARS-CoV-2 case-clusters in Danish schools: a nationwide register-based observational study.
    Epidemiol Infect. 2023;151:e168.
    >> Share

  152. GERRITZEN I, Brus IM, Spronk I, Biere-Rafi S, et al
    Identification of post-COVID-19 condition phenotypes, and differences in health-related quality of life and healthcare use: a cluster analysis.
    Epidemiol Infect. 2023;151:e123.
    >> Share

  153. BLACKBURN AM, Han H, Gallegos A
    Cross-language validation of COVID-19 Compliance Scale in 28 languages.
    Epidemiol Infect. 2023;151:e119.
    >> Share

  154. ROGERS JH, Cox SN, Link AC, Nwanne G, et al
    Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study.
    Epidemiol Infect. 2023;151:e129.
    >> Share

  155. HADLEY L, Karachaliou Prasinou A, Christensen H, Ramsay M, et al
    Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK - ERRATUM.
    Epidemiol Infect. 2023;151:e108.
    >> Share

  156. KULIMBET M, Saliev T, Alimbekova G, Ospanova D, et al
    Study of seroprevalence of SARS-CoV-2 in Kazakhstan.
    Epidemiol Infect. 2023;151:e116.
    >> Share

  157. RIEKKINEN M, Kajova M, Eriksson M, Luukkainen A, et al
    Superspreading of SARS-CoV-2 Omicron BA.2.23 among vaccinated Finnish adults: symptomatic COVID-19 only contracted by those without recent infection.
    Epidemiol Infect. 2023;151:e113.
    >> Share

  158. TOAN DTT, Pham TH, Nguyen KC, Pham QT, et al
    Shift from a Zero-COVID strategy to a New-normal strategy for controlling SARS-COV-2 infections in Vietnam.
    Epidemiol Infect. 2023;151:e117.
    >> Share

    June 2023
  159. GUO Y, Zeng X, Li L, Wang L, et al
    The impact of HBV infection on clinical outcomes of COVID-19 patients: a systematic review and meta-analysis.
    Epidemiol Infect. 2023;151:e135.
    >> Share

  160. LUO Y, Li Y, Xiao S, Lei H, et al
    Comparative analysis of inflight transmission of SARS-CoV-2, influenza, and SARS-CoV-1.
    Epidemiol Infect. 2023 Jun 23:1-22. doi: 10.1017/S0950268823001012.
    >> Share

  161. RAPTI I, Asimakopoulos A, Liontos A, Kosmidou M, et al
    Association of patient characteristics with clinical outcomes in a cohort of hospitalised patients with SARS-CoV-2 infection in a Greek referral centre for COVID-19 - Corrigendum.
    Epidemiol Infect. 2023;151:e91.
    >> Share

  162. LEOPARDI S, Desiato R, Mazzucato M, Orusa R, et al
    One health surveillance strategy for coronaviruses in Italian wildlife.
    Epidemiol Infect. 2023;151:e96.
    >> Share

  163. HADLEY L, Karachaliou Prasinou A, Christensen H, Ramsay M, et al
    Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK.
    Epidemiol Infect. 2023;151:e98.
    >> Share

    May 2023
  164. HSU CY, Chen JK, Wikramaratna PS, Yen AM, et al
    Can ship travel contain COVID-19 outbreak after re-opening: a Bayesian meta-analysis.
    Epidemiol Infect. 2023;151:e99.
    >> Share

  165. SABIR QUA, Shafqat A, Aslam M
    Prediction of the COVID-19 transmission: a case study of Pakistan.
    Epidemiol Infect. 2023;151:e89.
    >> Share

  166. LUO E, Zhong Q, Wen Y, Cai J, et al
    Development and external validation of a prognostic tool for nonsevere COVID-19 inpatients.
    Epidemiol Infect. 2023;151:e128.
    >> Share

  167. CHANG H, Zhang X, Su H, Cai J, et al
    Epidemiological characteristics of paediatric Omicron infection during the outbreak of SARS-CoV-2 infection during March-May in 2022 in Shanghai, China.
    Epidemiol Infect. 2023;151:e81.
    >> Share

  168. SCHOEPS A, Walter J, Vogt M, Bent S, et al
    Direct and indirect vaccination effects on SARS-CoV-2 infection in day-care centres: Evaluating the policy for early vaccination of day-care staff in Germany, 2021.
    Epidemiol Infect. 2023;151:e80.
    >> Share

  169. SHI T, Huang L
    Prevalence of respiratory pathogens and risk of developing pneumonia under non-pharmaceutical interventions in Suzhou, China.
    Epidemiol Infect. 2023;151:e82.
    >> Share

    April 2023
  170. JOVANOVIC V, Milic M, Dotlic J, Cvjetkovic S, et al
    Mandatory and seasonal vaccination against COVID-19: Attitudes of the vaccinated people in Serbia.
    Epidemiol Infect. 2023;151:e83.
    >> Share

  171. FRILLI E, Amodeo D, Cevenini G, Nante N, et al
    Effectiveness of near-UVA in SARS-CoV-2 inactivation.
    Epidemiol Infect. 2023;151:e76.
    >> Share

  172. MERCKX J, Callies M, Kabouche I, Desombere I, et al
    SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among pupils and school staff: a prospective cohort study.
    Epidemiol Infect. 2023;151:e75.
    >> Share

  173. WHITEHEAD J, Gan H, Heerikhuisen J, Gray G, et al
    Inequities in COVID-19 Omicron infections and hospitalisations for Maori and Pacific people in Te Manawa Taki Midland region, New Zealand.
    Epidemiol Infect. 2023;151:e74.
    >> Share

  174. ALHARBI B, Jennison AV, Hicks V, Whiley DM, et al
    Decreased Neisseria gonorrhoeae genotypic diversity following COVID-19 restrictions in Queensland, Australia 2020.
    Epidemiol Infect. 2023;151:e67.
    >> Share

  175. PRABHU VG, Hand WR, Isik T, Song Y, et al
    Risk-adjusted policies to minimise perioperative staffing shortages during a pandemic: An agent-based simulation study.
    Epidemiol Infect. 2023;151:e66.
    >> Share

  176. AHMED A, DeWitt ME, Dantuluri KL, Castri P, et al
    Characterisation of infection-induced SARS-CoV-2 seroprevalence amongst children and adolescents in North Carolina.
    Epidemiol Infect. 2023;151:e63.
    >> Share

    March 2023
  177. GOODWIN B, Zia H, Lo DF
    Assessment of early and post COVID-19 vaccination antibody response in healthcare workers: a critical review.
    Epidemiol Infect. 2023;151:e52.
    >> Share

  178. ALLEN H, Tessier E, Turner C, Anderson C, et al
    Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England.
    Epidemiol Infect. 2023;151:e58.
    >> Share

  179. MIZOUE T, Yamamoto S, Oshiro Y, Inamura N, et al
    Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants.
    Epidemiol Infect. 2023;151:e48.
    >> Share

    February 2023
  180. CAPELASTEGUI F, Flannagan J, Augarde E, Tessier E, et al
    Making the invisible visible: using national surveillance data to identify people experiencing homelessness in England with COVID-19.
    Epidemiol Infect. 2023;151:e51.
    >> Share

  181. SALAMA M, Amitai Z, Sheffer R
    Demographic and clinical characteristics of children and adolescents hospitalised with laboratory-confirmed COVID-19 in the Tel-Aviv District, Israel, 2020-2022.
    Epidemiol Infect. 2023;151:e42.
    >> Share

  182. ZHOU Y, Li Z, Wu W, Xiao J, et al
    Transmission trends of the global COVID-19 pandemic with combined effects of adaptive behaviours and vaccination.
    Epidemiol Infect. 2023;151:e39.
    >> Share

  183. HU CY, Lei Y, Tang YW, Cui WS, et al
    Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19.
    Epidemiol Infect. 2023;151:e34.
    >> Share

  184. MAIER BF, Rose AH, Burdinski A, Klamser P, et al
    Estimating the share of SARS-CoV-2-immunologically naive individuals in Germany up to June 2022.
    Epidemiol Infect. 2023;151:e38.
    >> Share

    December 2022
  185. WARD T, Glaser A, Overton CE, Carpenter B, et al
    Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Epidemiol Infect. 2022;151:e32.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016